Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-20-012542

President and CEO acquired 15,450 shares (option exercise)

  • President and CEO gave up 5,343 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Culley Brian M · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-06-30 Exercise or conversion : show line 1 in the form +15,450 $0.87 $13,442 170,731 D
2020-06-30 Shares withheld for taxes : show line 2 in the form −5,343 $0.87 $4,648 165,388 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-06-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −15,450 123,600 D
Loading xslF345X03/ownership.xml…